Filing Details
- Accession Number:
- 0001181431-14-022240
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-06-03 13:43:35
- Reporting Period:
- 2014-05-29
- Filing Date:
- 2014-06-03
- Accepted Time:
- 2014-06-03 13:43:35
- Original Submission Date:
- 2014-06-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1281069 | J Neal Harte | Unit # 1 83 Church Street Winchester MA 01890 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-29 | 13,317 | $3.82 | 37,575 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-29 | 12,317 | $4.27 | 25,258 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-05-30 | 19,400 | $0.00 | 44,658 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock option (right to buy) | Disposition | 2014-05-29 | 13,317 | $0.00 | 13,317 | $3.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-06-21 | No | 4 | M | Direct |
Footnotes
- Represents shares sold to cover the exercise price of the option as part of a broker-assisted cashless exercise.
- Includes a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015.
- Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; and (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 21,570 shares of common stock held by the Reporting Person.
- The options vested in three equal installments on June 21, 2005, 2006 and 2007.
- This transaction was executed in multiple trades at prices ranging from $4.2647 to $4.2721. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
